Back to Researchers
Profile photo Annet van Royen-Kerkhof

Annet van Royen-Kerkhof

Full Professor

Strategic program(s):

Child Health Infection & Immunity

Biography

Dr A. van Royen-Kerkhof is senior consultant in Pediatric Immunology and Rheumatology at the department of Pediatric Immunolgy an Rheumatology of the Wilhelmina Children’s Hospital Utrecht, the Netherlands. She obtained her MD degree in 1990 at the Medical School of the University of Utrecht. She was trained as a paediatrician from 1991-1996 In Utrecht and Eindhoven (Catharina Ziekenhuis) In 2002 she achieved her specialist degree in Pediatric Immunolgy and Rheumatology. In 2005 she finished her PhD thesis on “Fcg-receptors in the clinics”.
The main focus of her clinical work is on Immune-Mediated Inflammatory Diseases, the research focus is on Juvenile Dermatomyositis.

Currently she is involved in the development of the Medical/Research Master programme SUMMA in the University Medical Center Utrecht (2016-present).

As a member of the Medical Ethical Committee she was involved in reviewing investigational protocols for research in children  and persons who are incapable of giving consent.

Currently she is involved in the national and international discussions on accessibility of (expensive) treatment in pediatric patients

Strategic program(s):

Child Health Infection & Immunity

Contact

aroyen@umcutrecht.nl
Pure profile

Research groups

Life sciences education research

Research aim

We aim to develop adaptive, creative, responsible future health professionals by investigating learning in education and at workplaces. This leads to evidence-informed education and innovations that foster the health domain.

Go to group

Recent publications

All publications
Adoption of new treatment options in non-systemic juvenile idiopathic arthritis (JIA) in clinical practice Hedda C Lamers, Erika Van Nieuwenhove, Sebastiaan J Vastert, Marc H A Jansen, Annet van Royen-Kerkhof, Joost F Swart, Sytze de Roock
Pediatric rheumatology online journal, 2025, vol. 23
Safety, immunogenicity and efficacy of the Shingrix vaccine in immunocompromised varicella zoster virus naïve pediatric patients Mohamad Hamad Saied, Noehaila El Bied, Lana Khoury, Sebastiaan J Vastert, Joost Swart, Annet van Royen, Erika van Nieuwenhove, Victorien M Wolters, Joris van Montfrans, Frans Verduyn Lunel, Sytze de Roock, Marc Jansen
Vaccine, 2025, vol. 64
Advances in juvenile dermatomyositis Saskia R Veldkamp, Laura van der Griend, Elsbeth Noppers, Wineke Armbrust, J Merlijn van den Berg, Petra C E Hissink Muller, Esther Hoppenreijs, Sylvia Kamphuis, Judith Wienke, Femke van Wijk, Annet van Royen-Kerkhof, Marc H A Jansen
Rheumatology (Oxford, England), 2025, vol. 64, p.5622–5628
Ready, Set, Clerkship Mila Van Dorst, Marije Lesterhuis, Renske De Kleijn, Annet Van Royen-Kerkhof, Marije Hennus
Perspectives on medical education, 2025, vol. 14, p.352-359
Persistent hypogammaglobulinemia after rituximab therapy in pediatric patients, prevalence and clinical outcomes Susanna P.C. Höppener, Saskia R. Veldkamp, Mark C.H. de Groot, Saskia Haitjema, Julia Drylewicz, Jaap Jan Boelens, Caroline A. Lindemans, Joris van Montfrans, Annet van Royen-Kerkhof, Marc H.A. Jansen
Clinical Immunology Communications, 2025, vol. 7, p.55-63
Targeting interferon responses in juvenile dermatomyositis Saskia R Veldkamp, Maud Reugebrink, Sanne W Evers, Thomas R J Moreau, Vincent Bondet, Wineke Armbrust, J Merlijn van den Berg, Petra C E Hissink Muller, Sylvia Kamphuis, Ellen Schatorjé, Eveline M Delemarre, Anneke J van der Kooi, Brigitte Bader-Meunier, Darragh Duffy, Mathieu P Rodero, Joost Raaphorst, Annet van Royen-Kerkhof, Marc H A Jansen, Femke van Wijk
Rheumatology (Oxford, England), 2025, vol. 64, p.5132-5141

Fellowships & Awards

  • Stichting KAISZ (WKZ estafetteloop):                                                 5000, -
  • OBI project (Novartis):                                                                      10.000,-
  • Guidelines NVKR (Abbott):                                                                 16.000,-
  • Basic research (Regulatory T cells in Juvenile Dermatomyositis)            30.000,-
  • (De Bas Stichting)
  • Prinses Beatrix Spierfonds:.                                                               185.955,-

 (Biomarkers voor ziekteactiviteit bij Juveniele Dermatomyositis)

  • SKMS project       Dure en Weesgeneesmiddelen                                60.000,-

Awards of AIO
Judith Wienke award Young Investigator Meeting EULAR/PReS, Rom4 Italy, June 9th 2015:

CXCL10, TNFR2 and Galectin-9 correlate with disease activity in Juvenile Dermatomyositis.

External positions

Member MCTC Steering committee - Advisory role in design of clinical trials to meet the needs of pediatric myositis patients - Myositis Clinical Trial Consortium

Lid Toetsingscommissie - Toetsvragen ontwerpen voor voortgangstoets in opleiding Kindergeneeskunde - Nederlandse Vereniging voor Kindergeneeskunde

Member EULAR-PAED Committee - Member working party to improve collaboration between EULAR and PReS on Rheumatic diseases - EULAR-PAED

Secretaris - Secretaris Landelijke interdisciplinaire werkgroep Myositis, verslaglegging, organisatie - Myositis Netwerk Nederland

Vice-chair - Internationale werkgroep voor diagnostiek en behandeling van Juveniele Dermatomyositis - SiG SHARE guidelines IMACS

Medisch Adviseur - Medisch advies over onderwerpen aangedragen door het stichtingsbestuur - DeBasstichting

Medisch Adviseur - Medisch advies over onderwerpen aangedragen door de werkgroep Myositis - Vereniging Spierziekten Nederland